Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Signing of Definitive Agreement to Acquire Drug Lab 118 (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Healthcare
Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > Fool me twice shame on me
View:
Post by wood56 on Jun 25, 2020 10:03am

Fool me twice shame on me

Obviously they don't even have the cash to hire an acoounting firm to do year end financials. I thought this was a good gamble but it appears I was wrong again. Snap, Crackle, Poop
Comment by Moonshiner592 on Jun 25, 2020 10:20am
... is there some funding that's going to be granted from BARDA ... of which they are expecting very soon ...that they want to report as part of their financials when they're released?
Comment by Chritters on Jun 25, 2020 10:45am
Starting to wonder myself ghezzz
Comment by Moonshiner592 on Jun 25, 2020 12:02pm
... we should be seeing something pivital for KLY in the upcoming weeks ... if the patent is granted ...and sales for R-107 begin?  ... I'm opening the champagne!
Comment by JMark80 on Jun 25, 2020 12:18pm
Sales for R107? WTF are you talking about?
Comment by JMark80 on Jun 26, 2020 9:08am
So when does R107 go on sale? Ha!
Comment by Moonshiner592 on Jun 26, 2020 9:21am
... you tell me.... Ha .. Ha! 
Claritas Pharmaceuticals Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities